Trial Profile
Clinical Trials Insight: 700040634
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 19 Jan 2009
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Novartis
- 19 Jan 2009 New trial record.
- 13 Jan 2009 This trial expected to be initiated during 2009, according to a Novartis media release.